KG

Kanav Goyal

Active Director Additional Director DIN 11439059
DIN 11439059 First appointment Dec 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Kanav Goyal

Data last updated:

Kanav Goyal is an Additional Director at Jamkas Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11439059
Primary Designation Additional Director
Industry Pharma
First Appointment 22 Dec 2025
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director22 Dec 20252021Active

Directorship timeline

Open interactive timeline →
Jamkas Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kanav Goyal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kanav Goyal

Kanav Goyal currently holds 1 directorship: Jamkas Pharmaceuticals Private Limited (Additional Director, since 22 Dec 2025).

Kanav Goyal was first appointed on 22 Dec 2025 as Additional Director at Jamkas Pharmaceuticals Private Limited.

The current boards of Kanav Goyal's companies include Gurjinder Singh (Jamkas Pharmaceuticals Private Limited), Manish Goyal (Jamkas Pharmaceuticals Private Limited), Rakesh Kumar (Jamkas Pharmaceuticals Private Limited), Rupali Singla (Jamkas Pharmaceuticals Private Limited), Sayam Mittal (Jamkas Pharmaceuticals Private Limited), Vaneet Jain (Jamkas Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available